REGN
Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)
$17
About Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
Details
Daily high
$801.44
Daily low
$779.96
Price at open
$786.03
52 Week High
$859.34
52 Week Low
$541.00
Market cap
80.8B
Dividend yield
0.47%
Volume
704,401
Avg. volume
696,962
P/E ratio
19.40
Regeneron Pharmaceuticals, Inc. - Common Stock News
Details
Daily high
$801.44
Daily low
$779.96
Price at open
$786.03
52 Week High
$859.34
52 Week Low
$541.00
Market cap
80.8B
Dividend yield
0.47%
Volume
704,401
Avg. volume
696,962
P/E ratio
19.40